3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Penile Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Anus Neoplasms
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
Lenalidomide
6
Dexamethasone
6
Cyclophosphamide
5
Bortezomib
5
fludarabine
3
carfilzomib
3
belantamab mafodotin
3
pomalidomide
2
fludarabine phosphate
2
Melphalan
2
Etoposide
2
pembrolizumab
1
isatuximab
1
elotuzumab
1
daratumumab
1
Whole-Body Irradiation
1
Thalidomide
1
Tacrolimus
1
Sirolimus
1
Resistance Training
1
Radiotherapy
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Methotrexate
1
Exercise
1
Equipment and Supplies
1
Doxorubicin
1
Cyclosporine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
entinostat
×
90 days
×
Clear all
No trials found.